1430063-87-8

Basic information

• Product Name: C₂₇H₃₇FO₃S
• Synonyms: C₂₇H₃₇FO₃S
• CAS NO: 1430063-87-8
• Molecular Weight: 460.653
• Mol File: 1430063-87-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: C₂₇H₃₇FO₃S(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₇H₃₇FO₃S(1430063-87-8)
• EPA Substance Registry System: C₂₇H₃₇FO₃S(1430063-87-8)

Safety Data

• Hazardous Substances Data: 1430063-87-8(Hazardous Substances Data)

Upstream product

• 734-32-7 estra-4-ene-3,17-dione 
• 1430063-56-1 C₂₂H₃₆O₂ 
• 28426-27-9 C₂₀H₃₂O₃ 
• 190596-19-1 17-hydroxy-19-nor-5α-androstan-3-one 
• 5696-58-2 5α-estrane-3,17-dione 
• 20808-12-2 fluoromethyl phenyl sulfone 
• 1430063-57-2 C₂₀H₃₀O 

Relevant articles and documents

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

Provided herein are 19-nor C3, 3-disubstituted steroids of Formula (I) : and pharmaceutically acceptable salts thereof; wherein R1, R2, R3, and R4are as defined herein, and A is a heteroaryl ring system comprising 3 or 4 nitrogens as defined herein. Such compounds are contemplated useful for the prevention and treatment of a variety of CNS-related conditions, for example, treatment of sleep disorders, mood disorders, schizophrenia spectrum disorders, convulsive disorders, disorders of memory and/or cognition, movement disorders, personality disorders, autism spectrum disorders, pain, traumatic brain injury, vascular diseases, substance abuse disorders and/or withdrawal syndromes, and tinnitus.

19-NOR NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF

Provided herein are 3,3-disubstituted19-nor-steroidal compounds according to Formula(I): and pharmaceutical compositions thereof. Such compounds are contemplated useful for the prevention and treatment of a variety of CNS-related conditions,for example, treatment of sleep disorders, mood disorders,schizophrenia spectrum disorders, disorders of memory and/or cognition, movement disorders,personality disorders,autism spectrum disorders, pain,traumatic brain injury, vascular diseases,substance abuse disorders and/or withdrawal syndromes, tinnitus, status epilepticus.